To evaluate the presence of serum protein biomarkers associated with the early phases of formation of carotid atherosclerotic plaques, label-free quantitative proteomics analyses were made for serum samples collected as part of The Cardiovascular Risk in Young Finns Study. Samples from subjects who had an asymptomatic carotid artery plaque detected by ultrasound examination (N = 43, Age = 30–45 years) were compared with plaque free controls (N = 43) (matched for age, sex, body weight and systolic blood pressure). Seven proteins (p </p
Because of the clinical significance of carotid atherosclerosis, the search for novel biomarkers has...
OBJECTIVES: Assessment of vascular risk in asymptomatic patients and the response to medical therapy...
The heterogeneity of atherosclerotic tissue has limited comprehension in proteomic and metabolomic a...
Background: Blood-based biomarkers of atherosclerosis have been used to identify patients at high ri...
BACKGROUND. The identification of patients with high-risk atherosclerotic plaques prior to the manif...
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manif...
OBJECTIVE: To identify causal pathophysiological mechanisms for atherosclerosis and incident cardiov...
Background and Aims: We demonstrated that targeted proteomics predicts the occurrence of Subclinical...
Purpose: To increase the proteome coverage of human atherosclerotic plaques and identify low-abundan...
Introduction: The evolving use of multiplex proteomic platforms provides an excellent tool for inve...
Cardiovascular disease (CVD) is the leading cause of death and loss of productive life years in the ...
To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in...
Cardiovascular disease is the leading cause of death, with atherosclerosis the major underlying caus...
Atherosclerotic coronary artery disease (CAD)-related deaths will continue to rise along with globa...
Extensive research has focused on the identification of novel plasma biomarkers to improve our abili...
Because of the clinical significance of carotid atherosclerosis, the search for novel biomarkers has...
OBJECTIVES: Assessment of vascular risk in asymptomatic patients and the response to medical therapy...
The heterogeneity of atherosclerotic tissue has limited comprehension in proteomic and metabolomic a...
Background: Blood-based biomarkers of atherosclerosis have been used to identify patients at high ri...
BACKGROUND. The identification of patients with high-risk atherosclerotic plaques prior to the manif...
BACKGROUND: The identification of patients with high-risk atherosclerotic plaques prior to the manif...
OBJECTIVE: To identify causal pathophysiological mechanisms for atherosclerosis and incident cardiov...
Background and Aims: We demonstrated that targeted proteomics predicts the occurrence of Subclinical...
Purpose: To increase the proteome coverage of human atherosclerotic plaques and identify low-abundan...
Introduction: The evolving use of multiplex proteomic platforms provides an excellent tool for inve...
Cardiovascular disease (CVD) is the leading cause of death and loss of productive life years in the ...
To study the associations of blood proteins with the presence of unstable atherosclerotic plaques in...
Cardiovascular disease is the leading cause of death, with atherosclerosis the major underlying caus...
Atherosclerotic coronary artery disease (CAD)-related deaths will continue to rise along with globa...
Extensive research has focused on the identification of novel plasma biomarkers to improve our abili...
Because of the clinical significance of carotid atherosclerosis, the search for novel biomarkers has...
OBJECTIVES: Assessment of vascular risk in asymptomatic patients and the response to medical therapy...
The heterogeneity of atherosclerotic tissue has limited comprehension in proteomic and metabolomic a...